Literature DB >> 22919866

Parkinsonian syndrome as a complication of systemic lupus erythematosus. Report of a case and review of the literature.

Raymond E Chemaly1, Aïda S Moussalli.   

Abstract

A 34-year-old woman has had systemic lupus erythematosus since 11 years, with multiple treatments and incomplete result. When examined in our department, she presented with a recent parkinsonian syndrome including bradykinesia, adiadochokinesia, cogwheel rigidity and postural tremor of hands. Deep tendon reflexes were increased. Brain MRI showed abnormal signal intensity in the periventricular white matter, internal capsule, brain stem, middle cerebellar peduncles and cerebellar hemispheres. She was treated with prednisone and mycophenolate for the lupus, and amantadine and benzhexol for the parkinsonian syndrome which resolved within ten months, while the lupus improved. There are 30 cases of Parkinson's disease as a complication of lupus reported in the literature. The pathogenesis may be cerebral vasculitis with ischemia, and antibodies against neurons, mainly dopaminergic. Twenty cases improved, eight of them with the treatment of the lupus alone.

Entities:  

Mesh:

Year:  2012        PMID: 22919866

Source DB:  PubMed          Journal:  J Med Liban        ISSN: 0023-9852


  3 in total

1.  The risk factors of avascular necrosis in patients with systemic lupus erythematosus: a meta-analysis.

Authors:  Kao-Kao Zhu; Wang-Dong Xu; Hai-Feng Pan; Min Zhang; Jing Ni; Fu-Yang Ge; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 2.  The role of innate and adaptive immunity in Parkinson's disease.

Authors:  George T Kannarkat; Jeremy M Boss; Malú G Tansey
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

Review 3.  Movement and Other Neurodegenerative Syndromes in Patients with Systemic Rheumatic Diseases: A Case Series of 8 Patients and Review of the Literature.

Authors:  Rikitha Menezes; Alexander Pantelyat; Izlem Izbudak; Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.